Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

RANASINGHE, RUCHIKA

NPI: 1104875715 · LAS VEGAS, NV 89121 · Specialist · NPI assigned 05/09/2006

$605K
Total Medicaid Paid
23,818
Total Claims
21,213
Beneficiaries
44
Codes Billed
2018-01
First Month
2021-06
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 12,315 $349K
2019 3,610 $64K
2020 5,553 $122K
2021 2,340 $69K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3,192 2,861 $195K
90460 Immunization administration through 18 years of age via any route, first or only component 2,397 2,262 $82K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 928 858 $75K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 846 823 $71K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 485 473 $41K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 305 292 $27K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 246 232 $24K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 452 447 $17K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 321 303 $17K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 459 430 $9K
99381 85 83 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 249 234 $6K
94010 187 144 $6K
94760 5,996 5,092 $6K
96110 Developmental screening, with scoring and documentation, per standardized instrument 693 587 $4K
95117 465 161 $3K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 86 75 $3K
90461 71 71 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 112 98 $2K
99188 180 176 $2K
96127 347 325 $1K
96161 268 200 $506.75
90472 Immunization administration, each additional vaccine (list separately) 15 15 $374.34
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 45 30 $328.44
99070 376 217 $259.00
94664 17 17 $216.02
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 14 13 $212.30
36416 104 101 $157.18
95024 22 16 $67.22
81003 47 47 $11.88
90651 91 88 $0.02
90698 666 647 $0.00
90686 1,004 921 $0.00
90744 284 273 $0.00
90680 260 253 $0.00
90633 182 180 $0.00
90670 726 699 $0.00
99173 1,057 1,002 $0.00
90710 135 133 $0.00
90685 191 188 $0.00
90734 70 66 $0.00
90621 26 26 $0.00
99072 41 27 $0.00
94150 75 27 $0.00